TP53 and melanoma: Treatment with SFN at 20 μM has been shown to decrease cell survival through activation of p38 and p53, which regulate the expression of pro-apoptotic proteins, such as Bak and PUMA, in both Bowes and SK-Mel-28 human melanoma cells [309].